CClinicalTrials.gg
TerminatedNCT05985395Updated Dec 11, 2025Results posted

HEART Camp Connect: A Feasibility Study

An interventional study of HEART Camp Connect in Heart Failure With Preserved Ejection Fraction, sponsored by University of Nebraska. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-11.

Sponsored by University of Nebraska · Not applicable, Interventional, and Health services research

Why this study was terminated
R01 grant received, had to terminate preliminary research

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Mar 2022, registered Aug 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study builds on the tested and refined HEART Camp intervention which has been shown to improve long-term adherence to exercise in individuals diagnosed with heart failure. HEART Camp Connect enhances HEART Camp by delivering the coaching via videoconference and providing access to hospital-based exercise facilities and online exercise programming. This prospective study uses a 2-group, randomized repeated measures experimental design with 3 data collection points baseline, Month 3, and Month 6.

Read the detailed description

Potential participants will be approached at a Heart Failure clinic at an academic medical center. As a secondary recruitment strategy, we will use a database that identifies patients who previously indicated their willingness to be contacted for clinical research.

Study personnel will obtain informed consent in person in a private room or over the phone facilitated by the academic medical center electronic consent process. Once consented, participants will complete cardiopulmonary exercise testing (CPET) to guide individual exercise prescriptions and protect against risks associated with exercise. CPET results that preclude safe exercise training (arrhythmia) or those with CPET results indicating cardio-respiratory fitness (females with maximum oxygen consumption ≥ 21ml/kg/min and males with oxygen consumption ≥ 24 ml/kg/min) will be withdrawn from the study.

Participants will be given instruction on the use of the heart rate monitor. Participants will wear their monitor exercise sessions for heart rate monitoring. Participants will also receive educational training via videos on topics such as exercising with heart failure, how medications impact exercise, and nutrition.

Participants will be instructed to wear a heart rate monitor and strive to meet a goal of 150 minutes of moderate-intensity exercise per week. Minutes toward adherence goals for the study will be calculated as time spent participating in a moderate-intensity activity and determined by their CPET results and personalized exercise prescription.

Each participant will be given access to an Omaha-based exercise coach that he/she will meet with weekly over Zoom for 30 minutes. Coaches will discuss exercise over the past week including problems, issues, concerns. Goals will be set, reviewed, assessed, and revised each week. For virtual exercise, all participants will access a Virtual Wellness Center.

02

Conditions studied

  • Heart Failure With Preserved Ejection Fraction

Keywords

  • exercise training
  • adherence
  • coaching
03

In context

Lead sponsor

University of Nebraska is the lead sponsor of 473 studies on the registry; 66 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 46 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Diagnosis of heart failure (HF) with an ejection fraction (EF) ≥50%
  • Age ≥18 years
  • English-speaking
  • Echocardiogram in prior 12 months
  • Stable pharmacologic therapy in past 30 days

Exclusion criteria

Exclusion Criteria:

  • Score\<6 on a diagnostic algorithm
  • Life-limiting illness precluding study completion
  • Clinical evidence of decompensated HF
  • Unstable angina or marked shortness of breath on exertion at \<2 metabolic equivalents
  • Myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker \<6 weeks
  • Orthopedic or neuromuscular disorders preventing participation in aerobic exercise
  • Cardiopulmonary exercise test results that preclude safe exercise
  • Unwilling/unable to complete pre-randomization procedures
  • Pregnancy
  • Implantable cardioverter-defibrillator
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    HEART Camp Connect

    Participants will have access to a virtual exercise platform or membership to a medical exercise facility. Participants will meet with a virtual exercise coach via Zoom on a weekly basis.

    Behavioral: HEART Camp Connect

  • No intervention
    Usual Care

    Participants will have access to a virtual exercise platform or membership to a medical exercise facility.

Interventions

  • BehavioralHEART Camp Connect

    Once eligible and enrolled, participants will complete 150 minutes of moderate-intensity exercise a week with help of a virtual exercise coach.

06

What researchers measure

Primary outcomes

  1. Exercise Adherence

    Exercise adherence is defined as a count of the number of participants meeting 120 minutes or more of moderate intensity exercise per week at the prespecified time point of 3 months.

    Time frame: 3 months

Secondary outcomes

  1. Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score

    KCCQ measures heart failure related health status. The overall summary score ranges from 0 to 100, with higher scores indicating better health status, typically interpreted in 25-point ranges as: very poor to poor (0-24), poor to fair (25-49), fair to good (50-74), and good to excellent (75-100). A change in score of 5 points or more is considered clinically meaningful.

    Time frame: 3 months

Other outcomes

  1. Smart Devices

    Measures is a count of the number of potential participants without smart devices at baseline. Participants without a smart device are loaned one for the duration of the study.

    Time frame: Baseline

07

Results

Posted Mar 20, 2025
Limitations and caveats
We initially planned to enroll 25 participants per arm but upon receipt of R01 funding the funds for this pilot study had to be forfeited. Therefore, only 7 were enrolled and completed. Data collection and analyses were limited.

Participant flow

Participant flow — Overall Study
MilestoneHEART Camp ConnectUsual Care
Started74
Completed43
Not completed31
Withdrew: Physician decision21
Withdrew: Withdrawal by subject10

Outcome measures

PrimaryExercise Adherence

Exercise adherence is defined as a count of the number of participants meeting 120 minutes or more of moderate intensity exercise per week at the prespecified time point of 3 months.

Time frame:
3 months
Reported as:
Count of participants · Participants
Exercise Adherence
ParticipantsHEART Camp ConnectUsual Care
Exercise Adherence11
SecondaryKansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score

KCCQ measures heart failure related health status. The overall summary score ranges from 0 to 100, with higher scores indicating better health status, typically interpreted in 25-point ranges as: very poor to poor (0-24), poor to fair (25-49), fair to good (50-74), and good to excellent (75-100). A change in score of 5 points or more is considered clinically meaningful.

Time frame:
3 months
Reported as:
Mean · units on a scale
Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score
units on a scaleHEART Camp ConnectUsual Care
Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score56.7 ± 14.357.4 ± 16.1
Other pre-specifiedSmart Devices

Measures is a count of the number of potential participants without smart devices at baseline. Participants without a smart device are loaned one for the duration of the study.

Time frame:
Baseline
Reported as:
Count of participants · Participants
Smart Devices
ParticipantsHEART Camp ConnectUsual Care
Smart Devices21

Adverse events

Collected over Events data collected for 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
HEART Camp Connect0/4 (0%)0/4 (0%)0/4 (0%)
Usual Care0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)HEART Camp ConnectUsual CareTotal
Mean69.5 ± 14.0170.3 ± 6.469.9 ± 10.6
Sex: Female, Male
Sex: Female, Male(Participants)HEART Camp ConnectUsual CareTotal
Female336
Male101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)HEART Camp ConnectUsual CareTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American011
White426
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)HEART Camp ConnectUsual CareTotal
United States437
Exercise Adherence
Exercise Adherence(Participants)HEART Camp ConnectUsual CareTotal
Count of participants000
Kansas City Cardiomyopathy Questionnaire Overall Summary Score
Kansas City Cardiomyopathy Questionnaire Overall Summary Score(units on a scale)HEART Camp ConnectUsual CareTotal
Mean46.3 ± 16.348.7 ± 17.147.7 ± 15.4
08

Study locations

1 site
  • University of Nebraska Medical Center
    Omaha, Nebraska 68198-5330, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 26, 2023
  • Informed consent form · Nov 13, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05985395
Lead sponsor
University of Nebraska
Responsible party
Sponsor
First posted
Aug 14, 2023
Start date
Mar 28, 2022
Primary completion
Nov 20, 2023
Completion
Nov 20, 2023
Results posted
Mar 20, 2025
Last update
Dec 11, 2025

Study contacts

Windy W Alonso, PhD, RN
principal investigator · University of Nebraska

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion